FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/068577 [Registered on: 07/06/2024] Trial Registered Prospectively
Last Modified On: 07/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Follow Up Study 
Study Design  Other 
Public Title of Study   Quality of life in Indian women with Gynecological cancers 
Scientific Title of Study   Quality of life in Indian women with Gynecological cancers :A Prospective observational study 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Shikha Nagar 
Designation  Junior Resident 
Affiliation  Aiims Rishikesh 
Address  Obs and Gynae department,level 6,Aiims Rishikesh

Dehradun
UTTARANCHAL
249203
India 
Phone  8576838553  
Fax    
Email  nagarshikha437@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shikha Nagar 
Designation  Junior Resident 
Affiliation  Aiims Rishikesh 
Address  Obs and Gynae department,level 6,Aiims Rishikesh

Dehradun
UTTARANCHAL
249203
India 
Phone  8576838553  
Fax    
Email  nagarshikha437@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shikha Nagar 
Designation  Junior Resident 
Affiliation  Aiims Rishikesh 
Address  Obs and Gynae department ,level 6, Aiims Rishikesh

Dehradun
UTTARANCHAL
249203
India 
Phone  8576838553  
Fax    
Email  nagarshikha437@gmail.com  
 
Source of Monetary or Material Support  
Aiims Rishikesh,Virbhadra marg,City- Rishikesh,State-Uttarakhand,Pin Code- 249203 
 
Primary Sponsor  
Name  none 
Address  not applicable 
Type of Sponsor  Other [] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Prof Shalini Rajaram  Aiims Rishikesh  Obs and Gynae Department ,level 6,Virbhadra marg,Rishikesh,uttarakhand
Dehradun
UTTARANCHAL 
9810704434

rajaram.shalini@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
All India Institute of Medical Sciences,Rishikesh Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C539||Malignant neoplasm of cervix uteri, unspecified, (2) ICD-10 Condition: C541||Malignant neoplasm of endometrium, (3) ICD-10 Condition: C58||Malignant neoplasm of placenta, (4) ICD-10 Condition: C569||Malignant neoplasm of unspecifiedovary,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  nil  nil  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Female 
Details  Patients with stage I to IV gynecological cancers including ovarian,uterine,cervical and gestational trophoblastic neoplasia
ECOG performance status 0-2 
 
ExclusionCriteria 
Details  1.Patients who have been previously treated for any cancer
2.Patients with previous history of psychiatric illness
3. Poor performance status (ECOG more than or equal to 3)
4. Age less than 18 years and more than 65 years 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Proportion of women with psychological problems (anxiety,depression),sexual dysfunction,body image disturbances ,unmet supporive care needs ,health related quality of life issues at diagnosos and at follow up in total cohort and in indiviual cancers   At diagnosis and 3 to 6 months follow up 
 
Secondary Outcome  
Outcome  TimePoints 
Number & comparison of women with varying grades of severity of psychological problems ,disturbances in sexual quality of life ,body image,unmet supportive care needs & health related quality of life ,issues in entire cohort & indiviual cancers   At diagnosis & 3 to 6 months follow up 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/06/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The aim of this protocol is to evaluate the quality of life parameters at diagnosis and at follow up in women with gynecological cancers namely ovarian, cervical, uterine and gestational trophoblastic neoplasia.
Hypothesis- The gynecological cancers causes significantly impact overall quality of life and with treatment ,it is more likely to improve.
 
Close